📰 Tracon Pharma News
Tracon Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tracon Pharma. Real-time updates on events, politics, business and more.
January 25, 2024
Under the agreement, Glenmark will get the license for KN035 (Envafolimab) in India, Asia Pacific, the Middle East, Africa, Russia, CIS, and Latin America, the company said in a statement.
January 25, 2024
Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd on Thursday said its arm Glenmark Specialty S A (GSSA) has signed a license agreement with Jiangsu Alphamab Biopharmaceuticals Co and 3D Medicines (Beijing) Co Ltd for KN035 (Envafolimab), used in cancer treatment. Latest News | Glenmark Inks Licensing Pact with Jiangsu Alphamab, 3D Medicines for Cancer Drug.
January 25, 2024
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS,...
January 25, 2024
Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd . (Glenmark), announced the signing...
January 25, 2024
Bengaluru : Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), today announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES (BEIJING) C
December 5, 2022
Give hope, Share Joy will help provide nutritious food to San Diegans who need us most right now. Every dollar donated provides 2 meals.